Clover Health Investments, Corp.CLOVNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

8 analysts·Limited coverage

13%

Rating Distribution

Strong Buy

00%

Buy

113%

Hold

450%

Sell

338%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 36% higher.

Bear Case

$3.00

+36%

Consensus

$3.00

+36%

Bull Case

$3.00

+36%

Price Range8 analysts

Low

Consensus

High

$3.00

Current Target

Current Price

$2.20

Upside to Target

$0.80

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.02(1 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+12.10%

EPS—

FY2028

Rev+7.75%

EPS+122.40%

FY2029

Rev+11.58%

EPS+166.67%

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+9.5%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Oct 21, 2025Leerink Partners

Clover Health (CLOV) PT Raised to $3 at Leerink Partners

Target:$3.00

+2.7%from $2.92

Dec 17, 2024Craig-Hallum

Clover Health initiated with a Buy at Craig-Hallum

Target:$6.00

+89.9%from $3.16

Aug 6, 2024Canaccord Genuity

Clover Health (CLOV) PT Raised to $2.50 at Canaccord Genuity

Target:$2.50

+34.3%from $1.86

Nov 16, 2022Citigroup

Citigroup Maintains Neutral on Clover Health Investments, Lowers Price Target to $1.8

Target:$1.80

+25.0%from $1.44

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance